Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Filed Chapter 11
Quarterly results
CC transcript
MiddleBrook Pharmaceuticals, Inc. (MBRKQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/19/2011 8-K Quarterly results
01/06/2011 8-K Bankruptcy or Receivership, Financial Statements and Exhibits
Docs: "Debtor's Modified Plan of Liquidation"
12/20/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report for the Period from November 1, 2010 to November 30, 2010"
11/22/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report for the Period from October 1, 2010 to October 31, 2010"
11/10/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Debtor's Plan of Liquidation",
"Disclosure Statement for the Debtor's Plan of Liquidation"
10/20/2010 8-K Form 8-K - Current report
09/20/2010 8-K Form 8-K - Current report
08/05/2010 8-K Completion of Acquisition or Disposition of Assets, Cost Associated with Exit or Disposal Activities, Departure of Directors ...
Docs: "MiddleBrook Pharmaceuticals Completes Sale of Assets"
07/21/2010 8-K Acquisition/merger/asset purchase announced
Docs: "Monthly Operating Report for the Period from June 1, 2010 to June 30, 2010"
05/20/2010 8-K Form 8-K - Current report
05/04/2010 8-K Filed for Chapter 11
Docs: "MiddleBrook Pharmaceuticals Files for Chapter 11 Bankruptcy Protection"
04/12/2010 8-K Form 8-K - Current report
03/23/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/15/2010 8-K Quarterly results
Docs: "Press Release issued March 12, 2010"
12/03/2009 8-K Form 8-K - Current report
11/05/2009 8-K Form 8-K - Current report
09/01/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "MiddleBrook Pharmaceuticals Announces Sales Force Realignment, Cost-Saving Measures Company Expects Annualized Savings of Approximately $15 Million"
08/06/2009 8-K Form 8-K - Current report
05/07/2009 8-K Form 8-K -- Current report
04/24/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/05/2009 8-K Form 8-K -- Current report
11/13/2008 8-K Quarterly results
Docs: "Press Release issued November 13, 2008"
11/04/2008 8-K Form 8-K -- Current report
10/23/2008 8-K Form 8-K -- Current report
09/10/2008 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "MiddleBrook Pharmaceuticals Announces Stockholder Approval and Closing of $100 Million Financing Transaction with Equity Group Investments"
08/14/2008 8-K Quarterly results
Docs: "Changed Since Last Report)",
"MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results"
07/30/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "MiddleBrook Pharmaceuticals Files Definitive Proxy Statement With Respect to Proposed $100 Million Investment from EGI"
07/08/2008 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Principal Offi...
Docs: "Form of Warrant Agreement",
"Registration Rights Agreement, by and among MiddleBrook Pharmaceuticals, Inc. and the investors named therein",
"Form of Voting Agreement",
"Securities Purchase Agreement, by and between MiddleBrook Pharmaceuticals, Inc. and EGI-MBRK, L.L.C",
"Agreement Regarding Redemption of Warrants and Exercise of Stock Purchase Right, by and among MiddleBrook Pharmaceuticals, Inc. and Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Special Situations Fund, L.P., Deerfield Special Situations Fund International Limited, Kef Pharmaceuticals, Inc., Lex Pharmaceuticals, Inc. and Deerfield Management, L.P",
"Executive Employment Agreement, between MiddleBrook Pharmaceuticals, Inc. and John S. Thievon",
"Executive Employment Agreement, between MiddleBrook Pharmaceuticals, Inc. and Dave Becker",
"Consulting Agreement, between MiddleBrook Pharmaceuticals, Inc. and John S. Thievon",
"Consulting Agreement, between MiddleBrook Pharmaceuticals, Inc. and Dave Becker",
"Consulting Agreement, between MiddleBrook Pharmaceuticals, Inc. and Edward M. Rudnic",
"Consulting Agreement, between MiddleBrook Pharmaceuticals, Inc. and Robert C. Low",
"MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG™"
05/13/2008 8-K Quarterly results
Docs: "Changed Since Last Report)",
"MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results"
04/10/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
03/04/2008 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
01/30/2008 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
12/04/2007 8-K Other Events
11/26/2007 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy